RNF31 Double Nickase Plasmid (h): sc-412436-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- RNF31 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- RNF31 Double Nickase Plasmid (h) and RNF31 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting RNF31. One or both designs may be available
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RNF31 Double Nickase Plasmid (h) | sc-412436-NIC | 20 µg | $410.00 | |||
RNF31 Double Nickase Plasmid (h2) | sc-412436-NIC-2 | 20 µg | $410.00 |
RNF31 encodes an E3 ubiquitin ligase that functions as the catalytic core of the linear ubiquitin chain assembly complex (LUBAC), generating Met1-linked ubiquitin chains that modulate signal transduction. Through regulation of NF-κB and innate immune signaling, RNF31 helps control inflammatory gene expression, apoptosis resistance, and cellular stress responses. Its activity influences ubiquitin-dependent remodeling of signaling complexes downstream of receptors such as TNFR and pattern-recognition receptors. Dysregulated RNF31/LUBAC function has been associated with altered immune homeostasis and oncogenic signaling contexts, making it a relevant target for mechanistic studies of ubiquitination-driven pathway control.
RNF31 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the RNF31 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within RNF31. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt RNF31 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of RNF31-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.